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alformations of cortical development (MCDs)
are brain malformations that result from abnormalities
affecting the normal processes of cortical development
and involving cells that under normal circumstances
would participate in formation of the cerebral cortex.
Epileptic seizures result from paroxysmal,uncontrolled
discharges of electricity from the brain that arise pre-
dominantly from the cerebral cortex.It is not surprising
therefore that MCDs are often associated with recur-
rent seizures,and that these seizures may be difficult to
control.The seizures in MCDs arise as a consequence
of either malpositioning of normal cortical neurons or
47
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Malformations of cortical development (MCDs) are macroscopic or microscopic abnormalities of the cerebral cortex
that arise as a consequence of an interruption to the normal steps of formation of the cortical plate. The human cor-
tex develops its basic structure during the first two trimesters of pregnancy as a series of overlapping steps, beginning
with proliferation and differentiation of neurons, which then migrate before finally organizing themselves in the
developing cortex. Abnormalities at any of these stages, be they environmental or genetic in origin, may cause dis-
ruption of neuronal circuitry and predispose to a variety of clinical consequences, the most common of which is epilep-
tic seizures. A large number of MCDs have now been described, each with characteristic pathological, clinical, and
imaging features. The causes of many of these MCDs have been determined through the study of affected individu-
als, with many MCDs now established as being secondary to mutations in cortical development genes. This review will
highlight the best-known of the human cortical malformations associated with epilepsy. The pathological, clinical,
imaging, and etiologic features of each MCD will be summarized, with representative magnetic resonance imaging
(MRI) images shown for each MCD. The malformations tuberous sclerosis, focal cortical dysplasia, hemimegalencephaly,
classical lissencephaly, subcortical band heterotopia, periventricular nodular heterotopia, polymicrogyria, and schizen-
cephaly will be presented.   
© 2008, LLS SAS Dialogues Clin Neurosci. 2008;10:47-62.the presence of abnormal cortical neurons which results
in abnormal cortical circuitry and a subsequent imbal-
ance between the excitatory (glutaminergic) and
inhibitory (γ-aminobutyric acid [GABA]ergic) systems
which would normally control electrical discharges and
prevent spontaneous abnormal electrical discharges and
seizures.
The precise incidence of MCDs is not known; how-
ever, they have been diagnosed with increased fre-
quency since the use of magnetic resonance imaging
(MRI) to investigate patients with epilepsy, mental
retardation, and congenital neurological deficits. It is
estimated that 25% to 40% of intractable or medica-
tion-resistant childhood epilepsy is attributable to
MCDs,
1,2 and that at least 75% of patients with MCDs
will have epilepsy.
3 A large number of MCDs have
now been identified and classified using embryologic,
genetic, and imaging criteria.
4 Contrary to previous
assumptions, the majority of these disorders are now
thought to have a genetic basis,although environmen-
tal causes such as in utero infection or ischemia are
still possible.At the time of preparation of this manu-
script,mutations in over 30 genes have been identified
as causes of MCDs.MCD syndromes with specific clin-
ical, imaging, and genetic criteria are being defined
and delineated.
The aim of this review is to discuss the main types of
MCDs encountered in clinical practice, highlighting
those MCDs in which epilepsy is a frequent accompa-
niment.The different MCDs shall be discussed in the
order in which they are currently classified, based on
the presumed timing of the “insult,” be it genetic or
environmental, within the overlapping stages of corti-
cal development.Each MCD shall be discussed in terms
of its pathological,clinical,imaging,and etiological fea-
tures.
MCDs as a consequence of abnormal 
neuronal and glial proliferation or 
differentiation
Tuberous sclerosis
Tuberous sclerosis complex (TSC) is a multisystem syn-
drome characterized by hamartomata in multiple organ
systems,including abnormal proliferation of neurons and
glia in the central nervous system.The brain is the most
frequently affected organ, but other organs including
skin,eyes,heart,and kidneys may be involved.
5Typical
brain abnormalities include cortical tubers,subependy-
mal nodules,and subependymal giant cell astrocytoma.
The pathological features of cortical tubers may be indis-
tinguishable from those of some forms of focal cortical
dysplasia (FCD),showing large bizarre neurons,atypical
astrocytes,and subpial fibrillary gliosis.
TSC is one of the most common causes of MCDs,with a
birth incidence of 1/6000.
6The clinical features of TSC are
highly variable, depending on what organ systems are
involved and the location of and severity of involvement
within the affected organs.Neurological symptoms include
seizures,intellectual disability,and behavioral problems.
Some patients may have minimal or no neurological fea-
tures despite showing abnormalities in other organ sys-
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Selected abbreviations and acronyms
FCD focal cortical dysplasia
HMEG hemimegencephaly
LIS lissencephaly
MCD malformation of cortical development
MRI magnetic resonance imaging
PMG polymicrogyria
PNH periventricular nodular heterotopia
SBH subcortical band heterotopia
SCZ schizencephaly
TSC tuberous sclerosis
Figure 1. Imaging features of tuberous sclerosis. Axial T2-weighted MRI
(left) and contrast-enhanced axial T1-weighted MRI (right). The
image on the left shows multiple focal areas of broadened gyri,
blurring of the gray-white junction and increased signal in the
subcortical white matter typical of cortical tubers. The image on
the right shows multiple subependymal nodules (arrows) con-
sistent with subependymal hamartoma and a large enhancing
lesion at the right foramen of Monro consistent with a giant cell
astrocytoma. MRI, magnetic resonance imagingtems or carrying a mutation in one of the two known TSC
genes,whilst others may be neurologically asymptomatic
despite known cerebral lesions.Seizures may commence
at any age and are usually partial seizures originating in
cortical tubers.Infantile spasms are common,with seizures
arising in infancy.The severity of neurological symptoms
in TSC generally correlates with the patient’s tuber count,
7
although this may not hold true for an individual patient.
Evidence suggests that the presence and severity of
epilepsy is the most important variable associated with
intellectual disability.
8,9 Overall, approximately 80% of
patients with TSC have epilepsy, whilst approximately
65% have intellectual disability of some degree.
5
MRI may show cortical tubers, subependymal nodules,
giant cell astrocytoma,and linear white matter abnormal-
ities, as shown in Figure 1. Computerized tomography
(CT) scanning may be required to adequately show calci-
fications,which are most commonly seen in subependymal
nodules. In addition to these typical findings, MRI may
also detect cerebellar tubers, subtle cortical dysplasia,
transmantle dysplasia,
10 hemimegalencephaly (HMEG),
11,12
focal megalencephaly,and cortical infoldings.
13
TSC is an autosomal dominant syndrome with high pen-
etrance. Based on the study of affected families, two
genes have been identified;TSC1 on 9q34 which codes
for hamartin,
14 and TSC2 on 16p13 which codes for
tuberin.
15 Ninety percent of patients with TSC will have
mutations in one of these genes.
16,17 Hamartin and tuberin
cooperate in pathways that control cell growth and thus
are associated with defective control of neuronal and
glial proliferation or differentiation.
Focal cortical dysplasia
The term “focal cortical dysplasia”(FCD) was first used
by Taylor et al in 1971 to describe a histological abnor-
mality seen in surgical specimens from 10 patients with
epilepsy.
18The abnormality was described as a “malfor-
mation,” visible by histology and characterized by the
“congregations of large,bizarre neurons…(and) in most
…cases, grotesque cells … present in the depths of
affected cortex and in the subadjacent white matter.”
Most methods of classification divide FCD according to
both the degree of dysplasia (architectural or cytoarchi-
tectural dysplasia) and the presence or absence of abnor-
mal cells,primarily balloon cells or large dysmorphic neu-
rons.
19-21 FCD shows a spectrum of severity in terms of its
gross morphology,topography,and microscopic features.
At the mildest end of the spectrum is “microdysgenesis,”
which is poorly defined and refers to subtle develop-
mental cortical abnormalities including neuronal het-
erotopia, undulations of cortical layering, or neuronal
clusters amongst cell-sparse areas.
22 Microdysgenesis has
been found at autopsy more commonly in those with
epilepsy compared with controls without epilepsy or
other neurological disorders,
23 as well as in surgical spec-
imens from patients with medically intractable
epilepsy.
22,24 Despite this,it is still unclear what degree of
“microdysgenesis”may fall within the normal spectrum.
25
It has been suggested that the term FCD only be applied
to lesions with architectural abnormalities such as dys-
lamination or the presence of abnormal cells within the
cortex.
26The extent of FCD may be highly variable,rang-
ing from focal areas involving part of a gyrus,to involve-
ment of one or more gyri to transmantle dysplasia,lobar
dysplasia,hemispheric dysplasia,or multifocal bilateral
dysplasia.
Apart from TSC,no particular dysmorphic,neurocuta-
neous,or multiple congenital anomaly syndromes have
been described in which FCD is a feature.The most com-
mon clinical sequelae of FCD are seizures,developmen-
tal delay or intellectual disability,and focal neurological
deficits.
27-29 Seizures from FCD may arise at any age from
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Figure 2. Imaging features of focal cortical dysplasia. Coronal T2-
weighted MRI (left) and axial T1-weighted MRI (right) of two
patients with focal cortical dysplasia. The image on the left
shows area of gyral irregularity and increased subcortical sig-
nal (arrow) consistent with cortical dysplasia with signal
change. The image on the right shows an area of unusual
gyral formation and underlying thickening and blurring of the
gray-white junction (arrow) consistent with cortical dysplasia
without signal change. (No signal increase was seen on T2
weighted images.) MRI, magnetic resonance imaging in utero seizures
30 until adulthood;however,patients usu-
ally present in childhood.
27 Extratemporal FCD is usually
associated with an earlier age of seizure onset than tem-
poral FCD.
27,31,32 Seizures may be simple partial,complex
partial, or secondarily generalized, depending on the
location of the FCD and the age of the patient. The
seizure disorder may be intractable and life-threatening,
33
and surgical resection of the area of FCD may be
required to control seizures,as they are often resistant to
anticonvulsant medications.FCD has been shown to be
intrinsically epileptogenic,both in vivo using corticogra-
phy during epilepsy surgery
34 and in vitro using cortex
resected from patients with intractable epilepsy.
35,36
FCD is rarely visible on CT,and may not be visible even
with high-quality MRI.Subtle abnormalities in gyration,
cortical thickness,and the gray-white junction may be a
clue to underlying FCD.
37 Some forms of FCD may show
increased signal on FLAIR and T2-weighted images
which has been thought to represent the presence of bal-
loon cells.
20,38,39White matter signal may be abnormal in
the region of a FCD producing intractable seizures.
26,40 It
is not clear whether this represents dysplastic white mat-
ter,or an effect of continued seizure activity producing
advanced myelination.Imaging examples of FCD with
and without T2 signal increase are shown in Figure 2.
Barkovich and colleagues have described two forms of
cortical dysplasia with characteristic imaging appear-
ances. In focal transmantle dysplasia (FTD) there is a
wedge of dysplastic tissue from the lateral ventricle to the
cortical surface.Histology showed the features of FCD
with balloon cells as well as white-matter astrogliosis,and
MRI shows a wedge of disorganized tissue with increased
T2 signal.
41 FTD may also be seen in patients with TSC.
Sublobar dysplasia is characterized by a deep infolding
of the cortex with a thickened cortex and possible poor
gray-white differentiation in the malformed region.There
are associated brain abnormalities including ventricular
dysmorphism and callosal and cerebellar dysgenesis.
Tissue was not available for pathological examination.
42
Another form of FCD affecting one or other posterior
quadrant of the brain has also been described as “pos-
terior quadrantic dysplasia.”
43This form of FCD is alter-
nately known by the clumsy term “hemihemimegalen-
cephaly.”
Apart from FCD due to TSC, the etiology of FCD
remains unknown.There is no good evidence for envi-
ronmental causes.There are no published multiplex pedi-
grees for typical forms of FCD other than families with
TSC.However homozygous mutations in the gene CNT-
NAP2 were recently identified in Amish children with
cortical dysplasia,macrocephaly,and intractable seizures
with subsequent language regression.
44
Hemimegalencephaly
HMEG is a brain malformation characterized by the
presence of an abnormally enlarged and dysplastic cere-
bral hemisphere.The contralateral cerebral hemisphere
usually appears normal,except for being compressed or
distorted,although a recent study demonstrated reduced
size.
45 Macroscopically,one hemisphere is enlarged and
there is usually cortical dysgenesis,white-matter hyper-
trophy, and a dilated and dysmorphic lateral ventricle.
The majority of the cerebral hemisphere is affected,with
no clear predilection for right or left hemisphere.
46The
microscopic features of HMEG can vary significantly.
These may include polymicrogyria (PMG),heterotopic
grey matter,cortical dyslamination,bizarre enlarged neu-
rons, balloon cells, blurring of the gray-white junction,
and an increase in the number of both neurons and astro-
cytes.
47-49
The clinical triad of HMEG is typically: (i) intractable
partial seizures from the neonatal period or early infancy,
(ii) hemiparesis,and (iii) developmental delay.
50Although
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Figure 3. Imaging features of hemimegalencephaly. Axial T2-wieghted
MRI (left) and coronal T2-weighted MRI (right) of an infant
with hemimegalencephaly showing an enlarged and dysmor-
phic left hemisphere containing an enlarged lateral ventricle,
periventricular heterotopic gray, excessive white matter, abnor-
mal white matter signal, and gyral irregularity suggestive of
polymicrogyria, all characteristic of hemimegalencephaly. MRI,
magnetic resonance imagingthe seizures are partial in origin, children may present
with tonic seizures,or infantile spasms and the electro-
clinical features of Ohtahara syndrome
51 or West syn-
drome.With the exception of the hemiparesis,the devel-
opmental abnormalities may in part be the consequence
of intractable seizures,and the developmental outcome
may be more favorable if seizures are well controlled
from an early age.
52,53 Seizures are usually resistant to
medical therapy and control may only be achieved by
surgery such as anatomical or functional hemispherec-
tomy.
53-55
HMEG has been seen in association with both neurocu-
taneous and overgrowth syndromes. Neurocutaneous
associations include the linear nevus sebaceous syn-
drome,
56 hypomelanosis of Ito,
57 tuberous sclerosis,
11 and
neurofibromatosis.
58Approximately 50% of cases of lin-
ear nevus sebaceous syndrome have associated HMEG.
59
On MRI the cortical gray matter is almost uniformly
abnormal,showing areas of thickening and gyral simpli-
fication similar to pachygyria or overfolding that resem-
bles polymicrogyria (PMG).In both cases the gray-white
junction appears indistinct. White matter is generally
markedly increased in volume,and often contains tissue
isointense to cortical gray matter,consistent with gray-
matter heterotopia.There may be white-matter signal
change consistent with either dysmyelination or
advanced myelination.
37,46The ipsilateral ventricle is usu-
ally enlarged and dysmorphic,often with extension of the
posterior horn of the lateral ventricle across the mid-
line.
46,60,61 There may be enlargement of the ipsilateral
cerebellar hemisphere and brain stem, an appearance
which has been named “total hemimegalencephaly.”
62
The typical imaging features of HMEG are shown in
Figure 3.
The etiology of HMEG remains unknown.There are no
clear environmental causes or associations with known
chromosomal abnormalities.It is generally assumed that
HMEG results from a defect leading to excessive prolif-
eration of both neurons and astrocytes and the known
association of HMEG with other disorders of cellular
proliferation such as TSC and neurofibromatosis sup-
ports this hypothesis.One study has shown the abnormal
expression of the L1 neural cell adhesion molecule
(L1CAM) in 10 children with HMEG compared with 23
controls.
63 L1CAM is known to be involved in regulation
of neuroblast migration and axonal development.
MCDs as a consequence of abnormal neu-
ronal migration
Classical lissencephaly
The term lissencephaly (LIS) has generally been used to
describe disorders in which the mature brain is deficient
in gyration.Classical LIS was previously known as “type
I”LIS.
64 Classical LIS is a different malformation to cob-
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Figure 4. Imaging features of classical lissencephaly contrasting the P>A
gradient with the A>P gradient. Axial T1-weighted MRI scans.
The image on the left shows near-complete agyria posteriorly
transitioning to pachygyria anteriorly. This is the P>A gradient
consistent with a mutation of the LIS1 gene. The image on the
right shows severe pachygyria anteriorly transitioning to mild
pachygyria posteriorly. This is the A>P gradient consistent with a
mutation of the DCX gene. MRI, magnetic resonance imaging
Figure 5. Imaging features of classical lissencephaly showing the four
severity grades. All images are T1- or T2-weighted MRI scans.
The top row shows axial scans and the bottom row coronal
scans. Grade 1 is near complete agyria, grade 2 is posterior
agyria and rudimentary shallow gyri anteriorly, grade 3 is pos-
terior agyria and anterior pachygyria, and grade 4 is general-
ized pachygyria. MRI, magnetic resonance imagingblestone LIS (or cobblestone dysplasia), previously
referred to as “type II LIS.”
64 The terms classical LIS,
type I LIS,and agyria/pachygyria all still appear in the
current literature and all refer to the same malformation.
The macroscopic hallmarks of classical LIS are reduced
or absent gyration combined with thickening of the cere-
bral cortex. Most cases are a combination of agyria
(absent gyration) and pachygyria (broad,simplified gyra-
tion),with total agyria or total pachygyria being unusual.
On macroscopic inspection the brain shows poorly devel-
oped Sylvian and Rolandic fissures and failure of oper-
cularization of the insular areas.
65 The brain size and
weight are usually at the lower range of normal.
Associated abnormalities may include enlarged lateral
ventricles,absence of the claustra and external capsules,
abnormalities of the corpus callosum,persistent cavum
septum pellucidum,hypoplasia of the pyramidal tracts,
heterotopia of the inferior olives,and less often abnor-
malities of the cerebellum. Microscopic examination
shows a thick and poorly organized cortex with four
rather than the normal six layers.
65-67 From the cortical
surface inwards,these consist of:(i) a poorly defined mar-
ginal zone with increased cellularity;(ii) a superficial cor-
tical gray zone with diffusely scattered neurons;(iii) a rel-
atively neuron-sparse zone;and (iv) a deep cortical gray
zone with neurons often oriented in columns.
68The deep
cortical gray zone is much thicker than the superficial cel-
lular layer,and consists of large numbers of neurons pre-
sumed to have arrested their migration prematurely.
Other forms of LIS have recently been described,includ-
ing LIS associated with cerebellar hypoplasia and RELN
mutations,
69 and LIS associated with agenesis of the cor-
pus callosum and ARX mutations.
70 The pathological
findings in these rarer forms of LIS may be somewhat
different to those described above.
68
The clinical manifestations of LIS are variable depend-
ing on:(i) the severity and topography of the malforma-
tion;(ii) associated congenital brain abnormalities;and
(iii) congenital abnormalities in other organ systems.
Intractable epilepsy may be an independent contributor
to intellectual disability and developmental delay.The
common clinical features of classical LIS include severe
or profound intellectual disability,early hypotonia (which
may persist or evolve to mixed axial hypotonia and limb
spasticity),epileptic seizures (usually presenting as infan-
tile spasms) and feeding problems.
71-75The Miller-Dieker
syndrome (MDS) is a contiguous gene deletion syn-
drome with the deletion of multiple genes at the tip of
the short arm of chromosome 17,including both the LIS1
and YWHAE (14-3-3ε) genes which are both required
for normal brain development.
76 Children with MDS
have a severe form of LIS associated with facial dys-
morphism and occasionally other congenital abnormali-
ties,and have a severely shortened life expectancy.
Moderate and severe forms of LIS can usually be diag-
nosed using CT scanning.The cerebral surface appears
smooth with absent opercularization and a characteristic
“figure eight” appearance.
77 Milder forms of LIS and
accompanying brain malformations such as cerebellar
abnormalities may be missed using CT scanning. Using
1.5T MRI the gyral pattern (agyria or pachygyria),thick-
ened cortex and other brain abnormalities can readily be
appreciated.
75 Several different patterns of LIS are recog-
nized using MRI,which led to development of a detailed
grading system
78,79 which considers both the severity of the
gyral pattern simplification and the gradient along the
anterior to posterior axis.Most patients have a posterior
to anterior (P>A) gradient in which the gyral malforma-
tion is more severe posteriorly than anteriorly.This pattern
is seen most often as a consequence of a mutation in the
LIS1 gene, but may also occur with mutations of
TUBA1A.
80 Others have the reverse anterior to posterior
(A>P) gradient,which is seen most commonly as a conse-
quence of mutations in the DCX gene.Figure 4 shows the
imaging features of the two main gradients of LIS, and
Figure 5 shows different grades of LIS severity.
Six genes associated with LIS syndromes have been iden-
tified,and in approximately 80% of cases,a genetic cause
can be found, usually an abnormality of the LIS1 or
DCX genes.
78,81The six known genes associated with cau-
sation of LIS are LIS1,
82 DCX,
83 ARX,
70 RELN,
69
YWHAE,
76 and TUBA1A.
84These genes are all known to
be required for optimal migration of neurons during
brain development.All but the ARX gene are required
for normal radial migration of neurons whereas the ARX
gene is required for normal tangential migration.
85
Mutations in the LIS1 gene are the most common cause
of LIS.
81The LIS1 protein is not only required for neu-
ronal migration,but it is also required for cellular prolif-
eration and intracellular transport (reviewed in ref 86).
Subcortical band heterotopia
Subcortical band heterotopia (SBH) is alternately known
as double cortex
87 or subcortical laminar heterotopia.
88
The term SBH is preferable to double cortex,as the het-
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erotopic gray matter lacks cortical lamination and orga-
nization,and does not resemble a cerebral cortex other
than being composed of gray matter.SBH is character-
ized macroscopically by bilateral bands of heterotopic
gray matter located in the white matter between the lat-
eral ventricular walls and the cortex.
65The overlying cor-
tex appears normal with the exception of mildly shallow
sulci.In the most typical forms,the bands are bilateral
and symmetric and slightly more prominent anteriorly.
89
Occasionally the bands are seen restricted to the frontal
lobes (partial frontal) or rarely the occipito-parietal
regions (partial posterior) and unilateral and asymmet-
ric bands have also been reported.
89,90There are usually
no associated brain anomalies or other congenital mal-
formations, although occasionally the SBH can merge
anteriorly with pachygyric cortex which has been
described as a “pachy-band.”
79 Microscopic examination
of SBH shows the band to consist of a superficial zone of
disorganized neurons,an intermediate zone of small neu-
rons with some columnar organization and a deeper zone
where the heterotopia may break into nodules.The over-
lying cortex has a normal histological appearance.
65All
forms of SBH are thought to be a defect of neuroblast
migration with neurons that fail to migrate completely
forming the heterotopic band.
91
Patients with SBH will usually have mild-to-moderate
intellectual disability and a mixed seizure disorder with
onset at any age,but occasionally delayed until the sec-
ond or third decade.
87,92,93The spectrum of epilepsy and
intellectual disability is wide with severity roughly cor-
relating with the thickness of the heterotopic band.
92
Typical SBH shows a striking skewing of sex ratio to
females,
87,91 although the malformation has rarely been
reported in males as well.
94-97 Occasional patients with
mild partial forms of SBH may appear asymptomatic.
90
Patients with SBH usually have no dysmorphic features
or other congenital anomalies.
SBH is rarely recognized using CT scanning and when
seen may be mistaken for lissencephaly,and partial forms
may be difficult to appreciate,even using MRI.MRI will
show a four-layered cerebral parenchyma composed of
(from ventricle to cortex); (i) normal periventricular
white matter;(ii) layer of heterotopic gray matter;(iii)
thin layer of subcortical white matter; and (iv) normal
cortical gray matter,
92 as shown in Figure 6.
Mutations in two genes have been identified as causing
SBH;the DCX gene and the LIS1 gene.The vast major-
ity of both sporadic and familial cases of the most com-
mon form of SBH (bilateral, symmetric, and with a
frontal predominance) are due to mutations of DCX.
89,98
As DCX is carried on the X chromosome males with
mutations in DCX will usually have classical
lissencephaly whereas females will have SBH. It is
assumed that females with SBH secondary to DCX
mutations have two populations of neurons;those with
the mutant gene inactive that migrate normally and form
the cortex,and those with the normal gene inactivated
that migrate abnormally and form the heterotopic band.
Carriers of mild DCX mutations may show no evidence
of SBH on MRI,but may have intellectual disability or
epilepsy.
99A few cases of posterior SBH have been found
to be due to somatic mutations of the LIS1 gene.
100 SBH
has also been reported in association with trisomy 9p
101
and in a family without mutations of either the DCX or
LIS1 genes,
102 suggesting that mutations in other genes
may also result in SBH phenotypes.
Periventricular nodular heterotopia
Heterotopia are defined as groups of cells found in an
inappropriate location in the correct tissue of origin.
Nodular gray matter heterotopia are relatively common
in the brain,most often found in the periventricular or sub-
cortical white matter,suggesting a failure of migration of
neurons normally destined for the cerebral cortex.They
are thus correctly defined as MCDs. Heterotopia may
occur in isolation,in association with other developmen-
tal anomalies of the brain or as part of a multiple congen-
Figure 6. Imaging features of subcortical band heterotopia. Sagittal (left)
and coronal (right) T1-weighted MRIs showing typical features
of subcortical band heterotopia with bilateral, symmetric band
of tissue with identical signal to cortical gray matter inter-
spersed in the subcortical white matter between the normal
cortex and the lateral ventricle. MRI, magnetic resonance
imagingital anomaly syndrome.Macroscopically,periventricular
or subependymal heterotopia are nodular masses of gray
matter adjacent to or protruding into the walls of the lat-
eral ventricles.They may be single,multiple,and separated
or contiguous.Microscopically,the heterotopic gray mat-
ter forms clusters of rounded,irregular nodules separated
from each other by layers of myelinated fibers.Both neu-
rons and glia may be present with a pattern ranging from
apparent disorganization to one with rudimentary lami-
nation.
103
The most frequent manifestation of periventricular nodu-
lar heterotopia (PNH) is epilepsy,occurring in 80% to
90% of patients with most having various types of partial
seizures, which are usually intractable.
104 Studies using
depth electrodes in patients with PNH and epilepsy have
shown the nodules to be intrinsically epileptogenic
105 and
temporal lobe surgery for patients with PNH and associ-
ated hippocampal sclerosis has generally been unsuc-
cessful.
106 Most patients with PNH have normal intelli-
gence,although the curve may be shifted slightly to the
left with an average IQ of approximately 85.This data
applies best to the more common forms of PNH, with
manifestations of the variant syndromes generally being
more severe.There is a skewed sex ratio towards females
among patients with bilateral PNH.
In typical PNH,MRI will show nodular masses of gray
matter,lying adjacent to the lateral ventricles and often
protruding into the lumen,as seen in Figure 7.The signal
intensity is identical to that of cortical gray matter.
Functional studies using fluorodeoxyglucose positron
emission tomography (FDG-PET) and hexamethyl-
propyleneamine oxime single positron emission com-
puted tomography (HMPAO-SPECT) have shown
changes in metabolic activity and perfusion to be almost
identical in the heterotopic nodules and normal overly-
ing cortex.
107 Most are located along the lateral ventricu-
lar walls,although they may occasionally be seen poste-
riorly or medially.The nodules may be single or multiple,
unilateral or bilateral,large or small,and symmetric or
asymmetric. They may be contiguous or separated to
resemble “pearls on a string.” PNH differ from the
subependymal nodules of TSC,which are usually smaller,
fewer, inhomogeneous, and calcified, and have signal
intensity resembling white matter.PNH may be associ-
ated with additional brain anomalies such as cerebellar
vermis hypoplasia,and is the most common MCD found
in association with hippocampal sclerosis.
24 Unilateral or
focal PNH may occur in combination with subcortical
nodular heterotopia (SNH) or in association with other
MCDs such as PMG.
3,108,109Typical bilateral PNH may be
associated with mild-to-moderate hypoplasia of the cor-
pus callosum or cerebellum,the latter primarily involv-
ing the vermis. Usually, PNH is limited to the periven-
tricular region but may occasionally form a larger mass
that may deform or displace the lateral ventricle.
Mutations in the FLNA gene were identified in families
with multiple affected members with bilateral periven-
tricular nodular heterotopia.
110 FLNA is located on the
long arm of the X-chromosome,and mutations in males
are thought to be lethal,thus explaining the female pre-
dominance of PNH. FLNA may be necessary for effi-
cient cell motility,
111 possibly by promoting actin networks
at the leading edge of motile cells or by keeping cells
attached to supporting cells until the necessary signal for
cell locomotion.Defects in these functions may account
for defective initiation of neuronal migration in bilateral
PNH.
110Although approximately 80% of familial cases of
PNH have FLNA mutations, mutations have been
detected in only approximately 20% of sporadic PNH
patients.
112Those with mutations usually have a typical
bilateral PNH pattern,
113 with most patients with atypical
PNH not having FLNA mutations.
112,114 An autosomal
recessive form of PNH with microcephaly has been
found to be due to mutations in the ARFGEF2 gene in a
small number of children from consanguineous parents.
115
Basic research
54
Figure 7. Imaging features of periventricular nodular heterotopia. Axial T1-
weighted MRI showing two patients with bilateral periventricu-
lar nodular heterotopia. manifest by nodules of tissue with iden-
tical signal to cortical gray matter located in the periventricular
region (arrows). The image on the left shows scattered nodules
separated by normal white matter, whereas the image on the
right shows contiguous nodules completely lining the lateral ven-
tricle. MRI, magnetic resonance imagingBilateral PNH is also described in association with struc-
tural abnormalities of chromosome 5p.
116 It is likely that
PNH is a genetically heterogeneous disorder secondary
to abnormalities of genes involved in neuroblast prolif-
eration or initiation of neuroblast migration.
MCDs as a consequence of 
abnormal cortical organization
Polymicrogyria
Polymicrogyria (PMG) refers to a cerebral cortex with
excessive microscopic gyration,and is probably one of
the most common of the MCDs.Macroscopically PMG
appears as an irregular cortical surface.The distribution
of PMG varies significantly from unilateral forms, to
bilateral symmetric and asymmetric forms.The perisyl-
vian cortex is the most frequently affected area and the
affected Sylvian fissures may appear extended and supe-
riorly orientated posteriorly as shown in Figure 8.PMG
is reported to occur at the periphery of many poren-
cephalic or hydranencephalic defects.
117,118There may be
a variety of associated brain malformations, including
ventriculomegaly and abnormalities of the corpus callo-
sum,brain stem,and cerebellum,although PMG is usu-
ally the isolated brain malformation.PMG may show a
variety of histological patterns, but all show abnormal
cortical lamination,excessive folding and fusion of adja-
cent gyri.
65Two main forms of PMG are described;unlay-
ered and layered,the latter of which has been described
as the “true”or “structured”PMG.
119 Occasionally,both
forms are found in the same patient,suggesting that they
may be variations of the same malformation.
120
The clinical sequelae of PMG are highly variable
depending on the extent and location of the PMG, the
presence of other brain malformations,and the influence
of complications such as epilepsy. In addition, PMG is
reported as an occasional component in multiple differ-
ent syndromes or disorders including metabolic disor-
ders,chromosome deletion syndromes,and multiple con-
genital anomaly syndromes.These patients may have a
wide spectrum of clinical problems other than those
attributable to the PMG.Some patients with PMG have
fewer clinical problems than would be expected for the
location and extent of cortex involved.The most com-
mon form of PMG involves the perisylvian regions in a
bilateral and symmetric pattern. The combination of
bilateral perisylvian PMG (BPP) associated with oro-
motor dysfunction and a seizure disorder has been called
the “congenital bilateral perisylvian syndrome,”and is
the best described syndrome with PMG.Detailed clini-
cal data is published in over 50 patients with this distrib-
ution of PMG,
121,122 with the first description appearing in
the German pathological literature in 1905.
123 Patients
with BPP typically have oromotor dysfunction including
difficulties with tongue (tongue protrusion and side to
side movement),facial and pharyngeal motor function
resulting in problems with speech production,sucking,
and swallowing,excessive drooling,and facial diplegia.
They may also have an expressive dysphasia in addition
to dysarthria.More severely affected patients have min-
imal or no expressive speech, necessitating the use of
alternate methods of communication such as signing.On
examination there is facial diplegia,limited tongue move-
ment,a brisk jaw jerk,and frequent absence of the gag
reflex.
121 In patients presenting in childhood there may be
other abnormalities including arthrogryposis,hemiple-
gia,and hearing loss,although there is limited pediatric
data available.
124There may be mild-to-moderate intel-
lectual disability in up to 75% of cases.
121 Motor dysfunc-
tion may include limb spasticity,although this is rarely
severe if present. Other patterns of PMG have been
described including unilateral perisylvian PMG,
125 bilat-
eral frontal PMG,
126 bilateral frontoparietal PMG,
127 bilat-
eral parasagittal parieto-occipital PMG,
128 bilateral pari-
eto-occipital PMG,
129 multilobar PMG,
130 and bilateral
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Figure 8. MRI features of polymicrogyria. T1-weighted parasagittal image
(left) of a patient with perisylvian polymicrogyria (PMG) showing
an abnormally extended Sylvian fissure surrounded by overfolded
gray matter with an irregular surface and stippling of the gray-
white junction (arrows). The image on the right is a 3D surface
reconstruction of another patient with perisylvian PMG high-
lighting the abnormal extension and orientation of the Sylvian
fissure. MRI, magnetic resonance imaginggeneralized PMG.
131The clinical features of these rarer
forms of PMG vary from those seen in BPP, although
epilepsy and some degree of developmental delay are
common accompaniments.
The frequency of epilepsy in PMG is 60% to 85%,
121,122,132
although seizure onset may not occur until the second
decade,however usually between the ages of 4 and 12.
133
Seizure types include atypical absence (62%),atonic and
tonic drop attacks (73%),generalized tonic-clonic (35%)
and partial (26%).
133 It is rare for the partial seizures to
secondarily generalize. Occasionally patients develop
bilateral facial motor seizures with retained awareness.
A small number of patients may present with infantile
spasms
122,133,134 in contrast to patients with LIS, TSC, or
FCD, in which the frequency of spasms is higher.
Electroencephalography (EEG) typically shows gener-
alized spike and wave or multifocal discharges with a
centroparietal emphasis.
133 Seizures may be daily and
intractable in at least 50% of patients.
133
Using CT and low field strength MRI,PMG is difficult to
discern and may only appear as thickened cortex.
135-138The
only role for CT in the evaluation of PMG is to assess for
evidence of calcification which is seen in PMG resulting
from congenital CMV infection.Using high-quality 1.5T
MRI with appropriate age-specific protocols,it is now pos-
sible to reliably differentiate PMG from other MCDs.
139
Polymicrogyric cortex often appears mildly thickened (6
to 10 mm) on imaging due to cortical overfolding rather
than true cortical thickening.With better imaging (such as
inversion recovery) using thin contiguous slices,microgyri
and microsulci may be appreciated as shown in Figure 8.
T2 signal within the cortex is usually normal, although
there may be delayed myelination or high T2 signal in the
underlying white matter.
140 Diffusely abnormal white mat-
ter signal should raise the question of an in utero infection
(such as cytomegalovirus [CMV]) or a peroxisomal disor-
der.
141-143There may be an expansion of the subarachnoid
space over PMG,and this may contain excessive or anom-
alous venous drainage,especially in the Sylvian fissures.
140
Other developmental anomalies may also be seen includ-
ing ventricular enlargement or dysmorphism and abnor-
malities of the corpus callosum and cerebellum,although
the patterns and prevalence of these associated brain mal-
formations are poorly documented.
Few topics in the field of MCDs have generated as much
discussion as the etiology and pathogenesis of PMG.
Initial theories of PMG suggested that it was the result
of a vascular defect such as arterial ischemia.Numerous
etiologies,both genetic and nongenetic,have since been
reported in association with PMG. Nongenetic causes
other than hypoxia or hypoperfusion mainly relate to
congenital infections including CMV.
141,144-146There are a
multitude of reports of PMG in association with genetic
factors, either as part of a known genetic disease or a
multiple congenital anomaly syndrome, in association
with a structural chromosomal abnormality,or in fami-
lies with multiple affected members and/or consanguin-
ity.There is an association of PMG with some metabolic
diseases including Zellweger syndrome, although the
pathological changes differ from typical PMG.
143,147,148
Zellweger syndrome has been found to be due to muta-
tions in the PEX family of genes.
149,150 Despite the long-
held assumption that most forms of PMG are the result
of a nongenetic insult, familial cases and examples of
PMG occurring in other genetic syndromes and struc-
tural chromosomal abnormalities are now abundant in
the literature,as reviewed in Jansen and Andermann.
151
All modes of inheritance have been suggested although
an X-linked inheritance pattern appears most frequent.
152
The gene for bilateral frontoparietal PMG has been iden-
tified as GPR56,yet the function of this gene in cortical
development is unclear.
153 Our experience and recent
data from the mouse suggest that the pathological
changes have features in common with cobblestone cor-
tical malformation rather than typical PMG.
154,155
Mutations in the gene SRPX2 have been found in one
family with BPP,
156 but thus far mutations in this gene
have not been reported in other patients with BPP.PMG
is also reported as a component of several chromosomal
deletion syndromes,particularly the 22q11.2 deletion syn-
dromes such as the DiGeorge and velocardiofacial syn-
dromes.
157
Schizencephaly
“Schizencephaly”(SCZ) is a term first used by Yakovlev
and Wadsworth in 1946 to describe “true clefts formed in
the brain as the result of failure of development of the cere-
bral mantle in the zones of cleavage of the primary cere-
bral fissures.”
158,159 SCZ is differentiated from clefts in the
cerebral mantle that arise as a consequence of destructive
lesions,which Yakovlev and Wadsworth call “encephalo-
clastic porencephalies,” now known simply as poren-
cephaly.As part of the definition of SCZ,the clefts must be
lined by abnormal gray matter described as “microgyria,”
a term now synonymous with PMG.Macroscopically,the
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lipped”or “closed-lipped,”as shown in Figure 9.In open-
lipped clefts, the walls of the clefts do not appose each
other. In closed-lipped clefts the walls of the cleft are
apposed and often fused, although a line of continuity
between the lateral ventricle and subarachnoid space is
usually visible (the “pia ependymal seam
158”). Clefts are
frontal or parietal in approximately 65%,and temporal or
occipital in approximately 35%.
160 Other brain malforma-
tions may accompany SCZ.Most are rare,with the excep-
tion of agenesis of the septum pellucidum which is present
in approximately 70% of cases.
161 Microscopically,the gray
matter lining the clefts of SCZ is consistent with PMG,
often indistinguishable from other forms of PMG.
The clinical features of SCZ are well described in the lit-
erature,and depend on two factors:(i) unilateral vs bilat-
eral SCZ and (ii) open vs.closed-lipped SCZ.Patients with
closed-lipped SCZ typically present with hemiparesis or
motor delay whereas patients with open-lipped SCZ typ-
ically present with hydrocephalus or seizures.
162 In a large
series of 47 children with different types of SCZ,Packard
et al found a prevalence of epilepsy in 57% and moderate-
to-severe developmental delay in 83%.The median age
for seizure onset was 13 months,although those with open-
lipped SCZ generally had seizure onset at an earlier age
than those with closed-lipped SCZ.The most common
seizure type was complex partial, although infantile
spasms,tonic,atonic,and tonic-clonic seizures were also
reported.The severity and type of seizures does not appear
to correlate with the topography of the SCZ.
162,163 Outcome
is worst for those with bilateral open-lipped SCZ and best
for those with unilateral closed-lip SCZ.
162,164A large num-
ber of patients have associated brain abnormalities which
may account for the severity of some cases.These included
agenesis of the septum pellucidum,focal cortical dyspla-
sia,and dysgenesis of the corpus callosum.
162,165An inter-
esting finding is that some patients with SCZ have rela-
tively minor clinical problems relative to the appearance
of their malformation.
166-169
Routine structural MRI scanning is usually sufficient to
diagnose SCZ and determine whether the SCZ is open- or
closed-lipped.Subtle SCZ may recognizable by a “puck-
ering”or “dimple”outwards of the lateral ventricle at the
point at which the cleft reached the ventricular margin
(seen in the left image in Figure 9).The cleft is lined by
gray matter.The presence of white matter or T2 signal
increase suggestive of gliosis lining the cleft suggests that
the lesion is porencephaly rather than SCZ.The gray mat-
ter lining the cleft has the imaging appearance of PMG
with apparent cortical thickening,an irregular surface,and
stippling of the gray-white interface.SCZ may be asym-
metric,and the contralateral hemisphere should be closely
evaluated for the presence of a milder SCZ or PMG of
another form.Agenesis of the septum pellucidum is a com-
mon finding and hypoplasia of the optic nerves may be
present in up to 30% of cases,placing some forms of SCZ
in the septo-optic dysplasia spectrum.
136,170
The etiology of SCZ remains highly controversial,and
there are likely both genetic and non-genetic causes.In
SCZ, there is definite evidence for nongenetic causes
such as congenital CMV infection
144,171 and in utero
ischemic insults.
172There is also now ample evidence sup-
portive of a genetic etiology for some cases of SCZ,
including reports of a number of familial cases.
173-175A few
patients with both familial and nonfamilial SCZ were
found to have mutations in the homeobox gene
EMX2.
176,177 Unfortunately,other researchers have failed
to reproduce these results,raising the question as to the
true role of EMX2 in SCZ.
174
Conclusion
MCDs are significant causes of neurological and devel-
opmental disability and epileptic seizures are an associ-
ated symptom in over three quarters of patients. The
seizures may arise at any age, but epilepsy will usually
commence in childhood and is often resistant to anti-
convulsant medications.Surgery may have a role in the
treatment of seizures caused by these malformations.
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Figure 9. Imaging features of schizencephaly. Coronal T1- (left) and axial
T1 (right)-weighted MRI scans. Both images show full-thickness
clefts lined by irregular gray matter (arrows). The image on the
left shows bilateral closed-lip schizencephaly (SCZ) and the image
on the right shows right open-lipped SCZ and agenesis of the
septum pellucidum. MRI, magnetic resonance imagingBasic research
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Malformaciones del desarrollo cortical 
y epilepsia
Las malformaciones del desarrollo cortical (MDC) son
anormalidades macro o microscópicas de la corteza
cerebral que surgen como consecuencia de una inte-
rrupción de las etapas normales en la formación de
la placa cortical. La corteza cerebral desarrolla su
estructura básica durante los dos primeros trimestres
del embarazo como una serie de etapas sobrepues-
tas, que se inician con la proliferación y diferencia-
ción de neuronas las cuales luego migran antes de
organizarse finalmente en la corteza desarrollada.
Las anormalidades en cualquiera de estas etapas,
sean ellas de origen ambiental o genético, pueden
causar interrupción de los circuitos neuronales y pre-
disponer a una variedad de consecuencias clínicas,
siendo las más comunes las convulsiones epilépticas.
Actualmente se ha descrito un gran número de
MDC, cada una con sus características patológicas, clí-
nicas y de imágenes. Las causas de gran parte de
estas MDC se han determinado mediante el estudio
de sujetos afectados, y actualmente se ha establecido
que muchas de ellas son secundarias a mutaciones
en genes del desarrollo cortical. Esta revisión destaca
lo mejor conocido de las malformaciones corticales
humanas asociadas con la epilepsia. Se resumen las
características patológicas, clínicas, de imágenes y
etiológicas de cada MDC, con imágenes representa-
tivas de resonancia nuclear magnética para cada una
de ellas. Se presentan las malformaciones de la escle-
rosis tuberosa, displasia cortical focal, hemimega-
lencefalia, lisencefalia clásica, heterotopia subcorti-
cal en banda, heterotopia nodular periventricular,
polimicrogiria y esquizencefalia.     
Malformations du développement 
cortical et épilepsie
Les malformations du développement cortical (MDC)
sont des anomalies macroscopiques ou microsco-
piques du cortex cérébral qui surviennent comme
conséquence d’une interruption des étapes normales
de formation de la lame corticale. Le cortex humain
développe ses structures de base pendant les deux
premiers trimestres de la grossesse, par le biais d’une
série d’étapes chevauchantes, commençant par la
prolifération et la différenciation des neurones qui
migrent ensuite avant de s’organiser finalement
dans le cortex en développement. Les anomalies sur-
venant à chacune de ces étapes, qu’elles soient d’ori-
gine environnementale ou génétique, peuvent inter-
rompre le circuit neuronal et prédisposer à des
conséquences cliniques variées, la plus fréquente
étant les crises épileptiques. Un grand nombre de
MDC ont été décrites à ce jour, chacune avec ses
caractéristiques pathologiques, cliniques et d’ima-
gerie propres. Les causes de la plupart de ces MDC
ont été déterminées en étudiant les sujets atteints,
et de nombreuses MDC seraient secondaires des
mutations affectant des gènes du développement
cortical. Cet article mettra en évidence les malfor-
mations corticales humaines les plus connues asso-
ciées à l’épilepsie. Les caractéristiques pathologiques,
cliniques, d’imagerie et étiologiques de chaque MDC
seront résumées, des images d’IRM (imagerie par
résonance magnétique) illustrant chacune d’entre
elles. Les malformations telles la sclérose tubéreuse
de Bourneville, la dysplasie corticale focale, l’hé-
miencéphalomégalie, la lissencéphalie classique, l’hé-
térotopie en bandes sous-corticale, l’hétérotopie
nodulaire périventriculaire, la polymicrogyrie et la
schizencéphalie seront présentées.50. Trounce JQ, Rutter N, Mellor DH. Hemimegalencephaly: diagnosis and
treatment. Dev Med Child Neurol. 1991;33:261-266.
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